Mission
The NIMML Institute is a 501(c)(3) non-profit public charity foundation focused on a transdisciplinary, team-science approach to precision medicine at the interface of immunology, inflammation, and metabolism. It combines the expertise of immunologists, computational biologists, toxicologists, modelers, translational researchers, and molecular biologists to solve important societal problems through a view of the immune system as a massively and dynamically interacting system, applying advanced computational methods for therapeutic discovery.
Basic Information
Tax-Exempt
Founded in
2019
EIN
84-2520149
Total Assets
$0
At a Glance
Publication Insights on Systemic Lupus Erythematosus
Announced new mechanistic insights on the immunometabolic control of systemic lupus erythematosus.
Positive First-in-Human Data of NIM-1324
Presented at the American College of Rheumatology Convergence 2023.
Launch of TITAN-X A.I. Powered Platform
Validated through AbbVie’s acquisition of Landos Biopharma.
Impact Stats
$40 million
Contract Value
NIH/NIAID IDIQ Contract
Developed alternative preclinical models of enteric pathogens with a $40-million contract.
$1.7 million
Grant Value
MIDK-cWMD Grant
Leveraged computational modeling to model infectious disease kinetics with a $1.7 million grant.
$12 million
Funding Amount
NIAID-funded Program
Focused on the development of tools for studying mucosal immune responses with a $12-million funding.
Testimonials
"Working in the NIMML lab this semester has been an amazing experience! I have learned an enormous amount this semester and expanded my knowledge of molecular medicine."
Kindell Schmitt
Student
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
48
46
/100
Program Expense Ratio
88.62%
20
/20
Program Revenue Growth
426.49%
20
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
0
2
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 0 | 0.00% |
| Program Services | 274.3K | 51.14% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 262.1K | 48.86% |
| Total Revenue | 536.4K | 100.00% |
Related Nonprofits
Bioneomed Research Foundation
Med Research
Clinical Medical ResearchSociety of Biomolecular Imaging and Informatics
Med Research
Clinical Medical ResearchOral and Maxillofacial Surgery Foundation
Med Research
Clinical Medical ResearchAmerican Burn Association Inc.
Med Research
Clinical Medical ResearchUrology Research and Education Foundation
Med Research
Clinical Medical Research